[Form 4] Cirrus Logic Inc Insider Trading Activity

Rhea-AI Filing Summary

Jeffrey W. Baumgartner, Executive Vice President, R&D of Cirrus Logic, Inc. (CRUS), executed matched option exercise and sale transactions on 09/02/2025 under a Rule 10b5-1 trading plan adopted August 20, 2024. He exercised a non-qualified stock option with an exercise price of $38.34 for 10,000 shares and simultaneously sold 10,000 common shares at a weighted average price of $111.7811 (individual sale prices ranged from $111.05 to $112.47).

Following these transactions the reporting person beneficially owned 14,001 shares and held 7,391 derivative securities. The option exercised was fully vested (final vesting completed 05/02/2022) and has an expiration of 05/02/2028. The Form 4 was signed by attorney-in-fact Gregory Scott Thomas on 09/03/2025.

Positive

• Transaction executed under a Rule 10b5-1 plan, indicating the trades were pre-planned
• Option exercised at $38.34 with corresponding sale proceeds documented (weighted average sale price reported)

Negative

• Insider sold 10,000 shares, reducing direct beneficial ownership from 24,001 to 14,001 shares
• Derivative holdings decreased (10,000-option exercise reduced option exposure; 7,391 derivative securities remain)

Insights

Securities Analyst

TL;DR: Routine, pre-planned exercise and sale under a 10b5-1 plan; no new disclosure of company fundamentals.

The filing documents a contemporaneous exercise of 10,000 non-qualified stock options at an exercise price of $38.34 and immediate sale of 10,000 shares at a weighted average of $111.7811, executed pursuant to a Rule 10b5-1 plan adopted August 20, 2024. The transactions change the reporting persons direct common stock holding to 14,001 shares and leave 7,391 derivative securities outstanding. For investors, this is a disclosure of insider liquidity activity rather than new operational or financial information about Cirrus Logic.

Corporate Governance Expert

TL;DR: Governance procedures followed: transaction executed under a documented 10b5-1 plan and documented by attorney-in-fact.

The report shows adherence to a pre-established trading plan (10b5-1) adopted 08/20/2024, with the Form 4 executed by an attorney-in-fact on 09/03/2025. The filing also includes required footnote disclosure on weighted-average sale prices. This filing addresses compliance and disclosure obligations; it does not indicate any unusual governance events or undisclosed related-party transactions.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baumgartner Jeffrey W

(Last) (First) (Middle)

800 WEST 6TH STREET

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CIRRUS LOGIC, INC. [ CRUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, R&D

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		M(1)		10,000	A	$38.34	24,001	D
Common Stock	09/02/2025		S(1)		10,000	D	$111.7811(2)	14,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$38.34	09/02/2025		M(1)			10,000	(3)	05/02/2028	Common Stock	10,000	$0	7,391	D

Explanation of Responses:

1. This transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 20, 2024.

2. The price reported in Table I - Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.05 to $112.47. The reporting person will provide full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to any security holder of Cirrus Logic, Inc. or the staff of the SEC upon request.

3. Only vested shares can be exercised under this option. 25% of the shares vested on 05/02/19; the remaining shares vested monthly over the following 36 months so that the option was fully vested and exercisable on 05/02/22.

Remarks:

	By: Gregory Scott Thomas attorney-in-fact For: Jeffrey Baumgartner	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did the CRUS insider report on the Form 4?

The filing reports that Jeffrey W. Baumgartner exercised 10,000 non-qualified stock options at $38.34 on 09/02/2025 and sold 10,000 common shares that same day at a weighted average price of $111.7811.

Were these trades executed under a 10b5-1 plan for CRUS?

Yes. The filing states the transactions were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on 08/20/2024.

How many shares does the reporting person beneficially own after the transactions?

After the reported transactions the reporting person beneficially owned 14,001 common shares and held 7,391 derivative securities.

What price range were the sold shares executed at?

The footnote discloses the shares were sold in multiple transactions at prices ranging from $111.05 to $112.47, with a weighted average of $111.7811.

When did the option vest and when does it expire?

The option was fully vested by 05/02/2022 (25% vested 05/02/2019 with remaining monthly vesting) and the expiration date is 05/02/2028.